(Q40628938)

22 September 2017

title

Telomerase inhibition using azidothymidine in the HT-29 colon cancer cell line (English)

1 reference

22 September 2017

Telomerase Inhibition Using Azidothymidine in the HT-29 Colon Cancer Cell Line (English)

1 reference

https://api.crossref.org/works/10.1245/ASO.2003.03.032

18 March 2024

1 reference

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1245/ASO.2003.03.032

18 March 2024

1 reference

https://api.crossref.org/works/10.1245/ASO.2003.03.032

18 March 2024

author name string

Tommy Brown

1

1 reference

22 September 2017

Elin Sigurdson

2

1 reference

22 September 2017

Andre Rogatko

3

1 reference

22 September 2017

Dominique Broccoli

4

1 reference

22 September 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14527910

18 March 2024

publication date

1 October 2003

1 reference

full work available at URL

22 September 2017

http://link.springer.com/article/10.1245/ASO.2003.03.032/fulltext.html

1 reference

https://api.crossref.org/works/10.1245/ASO.2003.03.032

http://link.springer.com/content/pdf/10.1245/ASO.2003.03.032.pdf

18 March 2024

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1245/ASO.2003.03.032

http://link.springer.com/content/pdf/10.1245/ASO.2003.03.032

18 March 2024

1 reference

https://api.crossref.org/works/10.1245/ASO.2003.03.032

Annals of Surgical Oncology

18 March 2024

published in

1 reference

22 September 2017

volume

10

1 reference

22 September 2017

issue

8

1 reference

22 September 2017

page(s)

910-915

1 reference

Extension of life-span by introduction of telomerase into normal human cells

22 September 2017

cites work

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1126/SCIENCE.279.5349.349

A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon

1

1 reference

https://api.crossref.org/works/10.1245/ASO.2003.03.032

Mammalian telomeres and telomerase

18 March 2024

2

1 reference

https://api.crossref.org/works/10.1245/ASO.2003.03.032

Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span

18 March 2024

3

1 reference

https://api.crossref.org/works/10.1245/ASO.2003.03.032

Inhibition of telomerase limits the growth of human cancer cells.

18 March 2024

5

1 reference

https://api.crossref.org/works/10.1245/ASO.2003.03.032

Telomere shortening and apoptosis in telomerase-inhibited human tumor cells

18 March 2024

6

1 reference

https://api.crossref.org/works/10.1245/ASO.2003.03.032

Telomerase contributes to tumorigenesis by a telomere length-independent mechanism

18 March 2024

7

1 reference

https://api.crossref.org/works/10.1245/ASO.2003.03.032

Constitutive telomerase expression promotes mammary carcinomas in aging mice

18 March 2024

8

1 reference

https://api.crossref.org/works/10.1245/ASO.2003.03.032

Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends

18 March 2024

9

1 reference

https://api.crossref.org/works/10.1245/ASO.2003.03.032

Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer

18 March 2024

10

1 reference

https://api.crossref.org/works/10.1245/ASO.2003.03.032

Effects of reverse transcriptase inhibitors on telomere length and telomerase activity in two immortalized human cell lines

18 March 2024

11

1 reference

https://api.crossref.org/works/10.1245/ASO.2003.03.032

Telomerase inhibitors: targeting the vulnerable end of cancer?

18 March 2024

12

1 reference

https://api.crossref.org/works/10.1245/ASO.2003.03.032

Intravenous azidothymidine with fluorouracil and leucovorin: a phase I-II study in previously untreated metastatic colorectal cancer patients

18 March 2024

13

1 reference

https://api.crossref.org/works/10.1245/ASO.2003.03.032

High-dose intravenous zidovudine with 5-fluorouracil and leucovorin. A phase I trial

18 March 2024

14

1 reference

https://api.crossref.org/works/10.1245/ASO.2003.03.032

Control of telomere length by the human telomeric protein TRF1

18 March 2024

15

1 reference

https://api.crossref.org/works/10.1245/ASO.2003.03.032

Specific Association of Human Telomerase Activity with Immortal Cells and Cancer

18 March 2024

16

1 reference

https://api.crossref.org/works/10.1245/ASO.2003.03.032

Telomerase activity in normal and malignant hematopoietic cells

18 March 2024

17

1 reference

https://api.crossref.org/works/10.1245/ASO.2003.03.032

Structure, subnuclear distribution, and nuclear matrix association of the mammalian telomeric complex

18 March 2024

18

1 reference

https://api.crossref.org/works/10.1245/ASO.2003.03.032

Telomerase activation in mouse mammary tumors: lack of detectable telomere shortening and evidence for regulation of telomerase RNA with cell proliferation

18 March 2024

19

1 reference

https://api.crossref.org/works/10.1245/ASO.2003.03.032

An approach to the assessment of therapeutic drug interactions with fixed combination drug products

18 March 2024

20

1 reference

https://api.crossref.org/works/10.1245/ASO.2003.03.032

Increased epidermal tumors and increased skin wound healing in transgenic mice overexpressing the catalytic subunit of telomerase, mTERT, in basal keratinocytes.

18 March 2024

22

1 reference

https://api.crossref.org/works/10.1245/ASO.2003.03.032

Telomere dysfunction increases cisplatin and ecteinascidin-743 sensitivity of melanoma cells

18 March 2024

23

1 reference

https://api.crossref.org/works/10.1245/ASO.2003.03.032

Inhibition of telomerase increases resistance of melanoma cells to temozolomide, but not to temozolomide combined with poly (adp-ribose) polymerase inhibitor

18 March 2024

24

1 reference

https://api.crossref.org/works/10.1245/ASO.2003.03.032

Attenuation of telomerase activity does not increase sensitivity of human melanoma cells to anticancer agents

18 March 2024

25

1 reference

https://api.crossref.org/works/10.1245/ASO.2003.03.032

Viral and cellular factors for resistance against antiretroviral agents

18 March 2024

26

1 reference

https://api.crossref.org/works/10.1245/ASO.2003.03.032

The toxicity of azidothymidine (AZT) on human and animal cells in culture at concentrations used for antiviral therapy

18 March 2024

27

1 reference

https://api.crossref.org/works/10.1245/ASO.2003.03.032

Decreased thymidine kinase levels in peripheral blood cells from HIV-seropositive individuals: implications for zidovudine metabolism.

18 March 2024

28

1 reference

https://api.crossref.org/works/10.1245/ASO.2003.03.032

Mitochondrial toxicity of antiviral drugs

18 March 2024

29

1 reference

https://api.crossref.org/works/10.1245/ASO.2003.03.032

A highly selective telomerase inhibitor limiting human cancer cell proliferation

18 March 2024

30

1 reference

https://api.crossref.org/works/10.1245/ASO.2003.03.032

18 March 2024

Identifiers

1 reference

Dimensions Publication ID

22 September 2017

1038262640

0 references

1 reference